|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.28/--
|
企业价值
8.82M
|
资产负债 |
每股账面净值
-1.10
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/29 07:57 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well asother receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology. |